Viscofan Bilan de santé
Santé financière contrôle des critères 5/6
Viscofan possède un total de capitaux propres de €932.5M et une dette totale de €243.1M, ce qui porte son ratio d'endettement à 26.1%. Son actif total et son passif total sont €1.4B et de €475.5M. L'EBIT de Viscofan est €197.5M ce qui fait que son ratio de couverture des intérêts 48.4. Elle dispose de liquidités et de placements à court terme de €64.7M.
Informations clés
26.1%
Ratio d'endettement
€243.11m
Dette
Ratio de couverture des intérêts | 48.4x |
Argent liquide | €64.67m |
Fonds propres | €932.49m |
Total du passif | €475.55m |
Total des actifs | €1.41b |
Mises à jour récentes de la santé financière
Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Recent updates
Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report
Oct 26Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)
Oct 08Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing
Sep 25Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today
Aug 17Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 02Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue
Jun 26Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 20Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All
Apr 11Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?
Apr 04Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio
Mar 18Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement
Jan 17Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?
Nov 15Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 29Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?
Aug 11Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374
May 04Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Apr 24The Returns At Viscofan (BME:VIS) Aren't Growing
Mar 02Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Feb 16Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Returns On Capital At Viscofan (BME:VIS) Have Stalled
Nov 29Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price
Nov 11Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger
Aug 03Viscofan's (BME:VIS) Returns Have Hit A Wall
May 03Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?
Mar 06Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Jan 15Returns At Viscofan (BME:VIS) Appear To Be Weighed Down
Dec 29Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Nov 24Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?
Oct 10With EPS Growth And More, Viscofan (BME:VIS) Is Interesting
Sep 23Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 19Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Aug 03A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)
May 17Viscofan (BME:VIS) Could Easily Take On More Debt
Apr 07Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?
Mar 04Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like
Feb 17Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 02A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Jan 18Why Viscofan's (BME:VIS) CEO Pay Matters
Dec 26Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon
Dec 13Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?
Dec 04The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come
Nov 19Analyse de la situation financière
Passif à court terme: Les actifs à court terme de VIS ( €793.1M ) dépassent ses passifs à court terme ( €336.8M ).
Passif à long terme: Les actifs à court terme de VIS ( €793.1M ) dépassent ses passifs à long terme ( €138.7M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de VIS ( 19.1% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de VIS est passé de 20.7% à 26.1% au cours des 5 dernières années.
Couverture de la dette: La dette de VIS est bien couverte par le flux de trésorerie opérationnel ( 87.5% ).
Couverture des intérêts: Les paiements d'intérêts de VIS sur sa dette sont bien couverts par l'EBIT ( 48.4 x couverture).